World Malaria Diagnostics Market - Opportunities and Forecasts, 2017 - 2023

Malaria is caused by the Plasmodium parasites and is transmitted by the female anopheles mosquito. Diagnosis of malaria includes detection by microscopy and blood tests. According to the WHO, in 2012, there were an estimated 203 million cases of malaria, which resulted in an estimated 627,000 deaths. Accurate and early diagnosis of malaria is important as the patients recover rapidly if treatment is started early and this has spurred investments in diagnostic techniques. This has led to technological advancements in development of rapid diagnostic tests and is the major driver for growth of this market. The challenges faced by this market are in accelerating the acceptance of diagnostic tests and their use in diagnosis of malaria. WHO updated its guidelines for treatment of malaria and it recommends testing all suspected cases of malaria. Initiatives by global partners have been undertaken to provide universal access to diagnostic kits.

Malaria Diagnostics Market by Technique

Diagnosis of malaria is by use of Rapid Diagnostic Tests (RDT’s), Molecular diagnostics and detection of parasites by microscopy. Malaria RDTs have revolutionized diagnosis of malaria and are in high demand. The tests are rapid with results available in 15- 30 minutes. The tests detect the presence of antigens of the malaria parasites. Different types of RDT’s are available for diagnosis, some detecting single species of plasmodium, while others are able to detect multiple species.

Malaria Diagnostics Market by Geography

Malaria diagnostic market is segmented into North America, Europe, Asia Pacific and Row. Asia Pacific and RoW dominate this market, as the prevalence of malaria is high in these regions. Africa has a high prevalence of malaria and majority of deaths are reported in these regions.

Competitive Analysis

The companies in this market include Beckman Coulter, bioMerieux, Bio-Rad Laboratories, Novartis Diagnostics, Seimens Healthcare, Ortho- Clinical Diagnostics and others. In April 2013, Lumora, a Molecular Diagnostic company, announced a partnership with Foundation for Innovative New Diagnostics (FIND) for developing a rapid, high throughput malaria diagnostic assay that would allow screening on a large scale.

High Level Analysis

According to Porter’s five forces model, the bargaining power of the buyer is high in this market as there are many suppliers producing diagnostic kits. The report analyzes the threat of substitutes and new entrants to this market. The Malaria diagnostic market is experiencing a surge in growth due to global initiatives to reduce the deaths caused by this disease. The report describes the efforts taken by governments for the widespread use of diagnostics. The key investment regions are analyzed based on future growth potential of this market.

Key Benefits

In depth analysis of various geographic segments would help companies make strategic plans for each region
Competitive analysis of key players helps in understanding the business strategies implemented by them
Porter’s five forces model and SWOT analysis would enable stakeholders to make strategic decisions for business development
Market estimations of the malaria diagnostic market are given, which would help in making development plans
Identification of key challenges that have to be overcome to achieve success in this market are discussed

Key Deliverables

Malaria Diagnostics Market is segmented by technique and geography.

Malaria Diagnostics Market by technique

Rapid Diagnostic Tests (RDT)
Molecular Diagnostics
Microscopy

Malaria Diagnostics Market by Geography

North America
Europe
Asia Pacific
Row.



* This report will be delivered in 12 Business Days. *